205 related articles for article (PubMed ID: 32184450)
21. Upregulation of the endothelin A (ET
McGrady NR; Minton AZ; Stankowska DL; He S; Jefferies HB; Krishnamoorthy RR
BMC Neurosci; 2017 Mar; 18(1):27. PubMed ID: 28249604
[TBL] [Abstract][Full Text] [Related]
22. Posterior pole retinal thickness in ocular hypertension and glaucoma: early changes detected by hemispheric asymmetries.
Salgarello T; Colotto A; Valente P; Petrocelli G; Galan ME; Scullica L; Falsini B
J Glaucoma; 2005 Oct; 14(5):375-83. PubMed ID: 16148586
[TBL] [Abstract][Full Text] [Related]
23. Laser-Induced Ocular Hypertension in a Mouse Model of Glaucoma.
Ramírez JM; Salobrar-García E; de Hoz R; Salazar JJ; Matamoros JA; Sánchez-Puebla L; López-Cuenca I; Fernández-Albarral JA; Ramírez AI
Methods Mol Biol; 2023; 2708():49-56. PubMed ID: 37558959
[TBL] [Abstract][Full Text] [Related]
24. P2X7 receptor antagonist protects retinal ganglion cells by inhibiting microglial activation in a rat chronic ocular hypertension model.
Dong L; Hu Y; Zhou L; Cheng X
Mol Med Rep; 2018 Feb; 17(2):2289-2296. PubMed ID: 29207073
[TBL] [Abstract][Full Text] [Related]
25. Bilateral retinal microglial response to unilateral optic nerve transection in rats.
Cen LP; Han M; Zhou L; Tan L; Liang JJ; Pang CP; Zhang M
Neuroscience; 2015 Dec; 311():56-66. PubMed ID: 26432953
[TBL] [Abstract][Full Text] [Related]
26. Predicting visual field loss in ocular hypertensive patients using wavelet-fourier analysis of GDx scanning laser polarimetry.
Essock EA; Gunvant P; Zheng Y; Garway-Heath DF; Kotecha A; Spratt A
Optom Vis Sci; 2007 May; 84(5):380-7. PubMed ID: 17502818
[TBL] [Abstract][Full Text] [Related]
27. A Minimally Invasive Experimental Model of Acute Ocular Hypertension with Acute Angle Closure Characteristics.
Chong RS; Busoy JMF; Tan B; Yeo SW; Lee YS; Barathi AV; Crowston JG; Schmetterer L
Transl Vis Sci Technol; 2020 Jun; 9(7):24. PubMed ID: 32832230
[TBL] [Abstract][Full Text] [Related]
28. Scanning laser polarimetric analysis of retinal nerve fiber layer thickness in Turkish patients with glaucoma and ocular hypertension.
Bozkurt B; Irkeç M; Karaagaoglu E; Orhan M
Eur J Ophthalmol; 2002; 12(5):406-12. PubMed ID: 12474924
[TBL] [Abstract][Full Text] [Related]
29. Caveolin-1 Protects Retinal Ganglion Cells against Acute Ocular Hypertension Injury via Modulating Microglial Phenotypes and Distribution and Activating AKT pathway.
Zhang L; Xu J; Liu R; Chen W; Chen Q; Hu W; Zhou L; Zhang R; Xu H; Lin D; Li X; Tang Z
Sci Rep; 2017 Sep; 7(1):10716. PubMed ID: 28878269
[TBL] [Abstract][Full Text] [Related]
30. Reduced retina microglial activation and improved optic nerve integrity with minocycline treatment in the DBA/2J mouse model of glaucoma.
Bosco A; Inman DM; Steele MR; Wu G; Soto I; Marsh-Armstrong N; Hubbard WC; Calkins DJ; Horner PJ; Vetter ML
Invest Ophthalmol Vis Sci; 2008 Apr; 49(4):1437-46. PubMed ID: 18385061
[TBL] [Abstract][Full Text] [Related]
31. Selective Vulnerability of Specific Retinal Ganglion Cell Types and Synapses after Transient Ocular Hypertension.
Ou Y; Jo RE; Ullian EM; Wong RO; Della Santina L
J Neurosci; 2016 Aug; 36(35):9240-52. PubMed ID: 27581463
[TBL] [Abstract][Full Text] [Related]
32. Evaluation of Retinal Nerve Fiber Layer Thickness and Ganglion Cell Complex Progression Rates in Healthy, Ocular Hypertensive, and Glaucoma Eyes With the Avanti RTVue-XR Optical Coherence Tomograph Based on 5-Year Follow-up.
Holló G; Zhou Q
J Glaucoma; 2016 Oct; 25(10):e905-e909. PubMed ID: 26950575
[TBL] [Abstract][Full Text] [Related]
33. Reproducibility of macular ganglion cell-inner plexiform layer thickness measurement with cirrus HD-OCT in normal, hypertensive and glaucomatous eyes.
Francoz M; Fenolland JR; Giraud JM; El Chehab H; Sendon D; May F; Renard JP
Br J Ophthalmol; 2014 Mar; 98(3):322-8. PubMed ID: 24307717
[TBL] [Abstract][Full Text] [Related]
34. Effects of Intravitreal Anti-VEGF Therapy on Glaucoma-like Progression in Susceptible Eyes.
Du J; Patrie JT; Prum BE; Netland PA; Shildkrot YE
J Glaucoma; 2019 Dec; 28(12):1035-1040. PubMed ID: 31633617
[TBL] [Abstract][Full Text] [Related]
35. Retinal Changes in Astrocytes and Müller Glia in a Mouse Model of Laser-Induced Glaucoma: A Time-Course Study.
Fernández-Albarral JA; de Hoz R; Matamoros JA; Chen L; López-Cuenca I; Salobrar-García E; Sánchez-Puebla L; Ramírez JM; Triviño A; Salazar JJ; Ramírez AI
Biomedicines; 2022 Apr; 10(5):. PubMed ID: 35625676
[TBL] [Abstract][Full Text] [Related]
36. Usefulness of optical coherence tomography parameters of the optic disc and the retinal nerve fiber layer to differentiate glaucomatous, ocular hypertensive, and normal eyes.
Anton A; Moreno-Montañes J; Blázquez F; Alvarez A; Martín B; Molina B
J Glaucoma; 2007 Jan; 16(1):1-8. PubMed ID: 17224742
[TBL] [Abstract][Full Text] [Related]
37. Electroretinogram and visual-evoked potential assessment of retinal and central visual function in a rat ocular hypertension model of glaucoma.
Georgiou AL; Guo L; Francesca Cordeiro M; Salt TE
Curr Eye Res; 2014 May; 39(5):472-86. PubMed ID: 24215221
[TBL] [Abstract][Full Text] [Related]
38. Relationship between central corneal thickness and retinal nerve fiber layer thickness in ocular hypertensive patients.
Henderson PA; Medeiros FA; Zangwill LM; Weinreb RN
Ophthalmology; 2005 Feb; 112(2):251-6. PubMed ID: 15691559
[TBL] [Abstract][Full Text] [Related]
39. Mouse model of ocular hypertension with retinal ganglion cell degeneration.
Mukai R; Park DH; Okunuki Y; Hasegawa E; Klokman G; Kim CB; Krishnan A; Gregory-Ksander M; Husain D; Miller JW; Connor KM
PLoS One; 2019; 14(1):e0208713. PubMed ID: 30640920
[TBL] [Abstract][Full Text] [Related]
40. Fractalkine receptor regulates microglial neurotoxicity in an experimental mouse glaucoma model.
Wang K; Peng B; Lin B
Glia; 2014 Dec; 62(12):1943-54. PubMed ID: 24989686
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]